Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Study to Compare AMG 510 "Proposed INN Sotorasib" With Docetaxel in Non Small Cell Lung Cancer (NSCLC) (CodeBreak 200).

ClinicalTrials.gov ID: NCT04303780

Public ClinicalTrials.gov record NCT04303780. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 18, 2026, 10:16 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3 Multicenter, Randomized, Open Label, Active-controlled, Study of AMG 510 Versus Docetaxel for the Treatment of Previously Treated Locally Advanced and Unresectable or Metastatic NSCLC Subjects With Mutated KRAS p.G12C

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

A Phase 3 Study to Compare AMG 510 with Docetaxel in Non Small Cell Lung Cancer (NSCLC) subjects with KRAS p. G12c mutation

Study identification

NCT ID
NCT04303780
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Amgen
Industry
Enrollment
345 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 100 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 4, 2020 (Actual)
Primary completion
Aug 2, 2022 (Actual)
Completion
Jun 24, 2026 (Actual)
Last update posted
Jul 22, 2026

2020 – 2026

United States locations

U.S. sites
54
U.S. states
26
U.S. cities
49
Facility City State ZIP Site status
Pacific Cancer Medical Center Inc Anaheim California 92801 —
City of Hope National Medical Center Duarte California 91010 —
Pacific Shores Medical Group Long Beach Long Beach California 90813 —
University of California Los Angeles Los Angeles California 90095-1772 —
University of California Los Angeles Los Angeles California 90095 —
University of California at Davis Medical Center Sacramento California 95817 —
Ridley Tree Cancer Center Santa Barbara California 93105 —
University of California San Francisco Mission Hall Stanford California 94305 —
Harbor University of California Los Angeles Medical Center Torrance California 90502 —
Rocky Mountain Cancer Centers Denver Colorado 80218 —
Danbury Hospital Norwalk Connecticut 06856 —
Medical Oncology Hematology Consultants Helen F Graham Cancer Center Newark Delaware 19713 —
Washington Cancer Institute at MedStar Washington Hospital Washington D.C. District of Columbia 20010 —
Florida Cancer Specialists - Fort Myers Fort Myers Florida 33901 —
Memorial Regional Hospital Hollywood Florida 33021 —
Florida Cancer Specialists Research North St. Petersburg Florida 33705 —
Florida Cancer Specialists Research Panhandle Tallahassee Florida 32308 —
Emory University Atlanta Georgia 30332 —
Northside Hospital, Incorporated Atlanta Georgia 30341 —
Affiliated Oncologists, LLC North Chicago Illinois 60064 —
Fort Wayne Medical Oncology and Hematology Fort Wayne Indiana 46804 —
Willis Knighton Cancer Center Shreveport Louisiana 71103 —
Maryland Oncology Hematology PA Clinton Maryland 20735 —
New York Cancer and Blood Specialists Lowell Massachusetts 01854 —
University of Michigan Ann Arbor Michigan 48109-1274 —
Center for Oncology Clinical Trials Grand Rapids Michigan 49503 —
Minnesota Oncology Hematology PA Minneapolis Minnesota 55404 —
HCA Midwest Health Kansas City Kansas City Missouri 64132 —
Comprehensive Cancer Centers of Nevada Las Vegas Nevada 89169 —
Summit Medical Group Florham Park New Jersey 07932 —
New York Oncology Hematology, PC Albany New York 12208 —
United States Oncology Regulatory Affairs Corporate Office Albany New York 12208 —
Northwell Health Monter Cancer Center Lake Success New York 11042 —
Montefiore Einstein Center for Cancer Care The Bronx New York 10461 —
James J Peters VA Medical Center The Bronx New York 10468 —
Wake Forest Baptist Health Winston-Salem North Carolina 27157 —
Oncology Hematology Care Inc Cincinnati Ohio 45219 —
Northwest Cancer Specialists - Vancouver Portland Oregon 97227 —
Charleston Oncology Charleston South Carolina 29414 —
Saint Francis Hospital, Inc Greenville South Carolina 29607 —
Tennessee Oncology PLLC Chattanooga Tennessee 37404 —
Tennessee Cancer Specialists Knoxville Tennessee 37909 —
Tennessee Oncology Nashville Tennessee 37203 —
Texas Oncology-Bedford Bedford Texas 76022 —
Texas Oncology Baylor Dallas Texas 75246 —
UT Southwestern Medical Center Dallas Texas 75390 —
The Center for Cancer and Blood Disorders Fort Worth Texas 76104 —
Valley Cancer Associates Harlingen Texas 78550 —
University of Texas MD Anderson Cancer Center Houston Texas 77030 —
US Oncology Research Investigational Products Center Irving Texas 75063 —
Hope Cancer Center Tyler Texas 75701 —
Intermountain Medical Center Murray Utah 84107 —
Virginia Cancer Specialists, PC Fairfax Virginia 22031 —
Virginia Oncology Associates Norfolk Virginia 23502 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 220 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04303780, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 22, 2026 · Synced Oct 18, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT04303780 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →